StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) bonds

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$74.18−3.48 (-4.48%)

Close on Nov 17, 2026Market cap $1.09BP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$276.70M
Long-term debt
Net debt
$77.23M
After $199.47M of cash
Implied interest rate
24.26%
FY2025 interest ÷ average debt
Interest coverage
-11.1×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Inhibrx Biosciences's 10-Q for the period ended Jun 30, 2026

Inhibrx Biosciences's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Oxford Term Loans$75.00M–
Secured Debt–$190.75M
Term A–$109.00M
Term B–$81.75M

See a number that looks wrong?